Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
12 May 2021
12 May 2021
Historique:
entrez:
20
5
2021
pubmed:
21
5
2021
medline:
21
5
2021
Statut:
epublish
Résumé
Individuals with acute malaria infection generated high levels of antibodies that cross-react with the SARS-CoV-2 Spike protein. Cross-reactive antibodies specifically recognized the sialic acid moiety on N-linked glycans of the Spike protein and do not neutralize
Identifiants
pubmed: 34013301
doi: 10.1101/2021.05.10.21256855
pmc: PMC8132281
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : FIC NIH HHS
ID : K01 TW010496
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148467
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA193200
Pays : United States
Organisme : NIAID NIH HHS
ID : K08 AI128043
Pays : United States
Commentaires et corrections
Type : UpdateIn
Références
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33261717
J Clin Microbiol. 2021 Apr 14;:
pubmed: 33853839
J Leukoc Biol. 2021 Jan;109(1):77-90
pubmed: 33617048
J Exp Med. 2013 Feb 11;210(2):389-99
pubmed: 23319701
Front Immunol. 2021 Apr 27;12:625311
pubmed: 33986742
Trop Med Int Health. 2021 Mar 5;:
pubmed: 33666297
Int J Infect Dis. 2021 Jan;102:577-583
pubmed: 33176202
Sci Rep. 2020 Mar 24;10(1):5294
pubmed: 32210339
Am J Trop Med Hyg. 2021 Jan;104(1):91-94
pubmed: 33185181
Nature. 2021 May 19;:
pubmed: 34010947
Sci Rep. 2016 Aug 02;6:30312
pubmed: 27481573
Science. 2021 Jan 1;371(6524):79-82
pubmed: 33177105
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
Cell. 2021 Apr 1;184(7):1858-1864.e10
pubmed: 33631096